Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Alzheimer Disease and Associated Disorders|July 14, 2010
Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trialSandi Culo, Benoit H Mulsant, Jules Rosen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 4, 2003
Half a century of antipsychotics and still a central role for dopamine D2 receptorsShitij Kapur, David Mamo
Drugs of Today (Barcelona, Spain : 1998)|September 23, 2008
Desvenlafaxine succinate for major depressive disorderBeth A Sproule, Monica Hazra, Bruce G Pollock
Bjpsych Bulletin|July 27, 2023
Mental health attitudes in Malta: a cross-sectional survey exploring the knowledge and perceptions of general practitioner traineesDaniela Zammit, Jonathan Grech, Patrick Abela, et al.
Psychiatry and Clinical Neurosciences|December 20, 2011
Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophreniaMonica Hazra, Hiroyuki Uchida, Beth Sproule, et al.
The International Journal of Neuropsychopharmacology|April 16, 2009
The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychoticsRomina Mizrahi, David Mamo, Pablo Rusjan, et al.
Dialogues in Clinical Neuroscience|February 9, 2010
The intersection of pharmacology, imaging, and genetics in the development of personalized medicinePhilip Gerretsen, Daniel J Müller, Arun Tiwari, et al.
The American Journal of Psychiatry|August 31, 2007
Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET studyDavid Mamo, Ariel Graff, Romina Mizrahi, et al.
Behavioral Sciences (Basel, Switzerland)|December 1, 2020
Improving Dignity of Care in Community-Dwelling Elderly Patients with Cognitive Decline and Their Caregivers. The Role of Dignity TherapyHeifa Ounalli, David Mamo, Ines Testoni, et al.
Psychopharmacology|March 10, 2004
EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET studyDavid Mamo, Ewen Sedman, Joachim Tillner, et al.
Pageof 4